RCS - Envista - DEXIS to Showcase Cutting-Edge Innovations

Envista HoldingsAnnouncement

24/03/2025 15:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250324:nRSX7304Ba&default-theme=true

RNS Number : 7304B  Envista  24 March 2025

DEXIS to Showcase Cutting-Edge Innovations at IDS 2025

QUAKERTOWN, PA / ACCESS Newswire (https://www.accessnewswire.com/)  / March
24, 2025 / DEXIS
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tdXM&sig=4yqQuhXOZxGUHGf-AFlynGat2s_cwMZxbRvLb4lNif8ZXeRx87bXacgzJrLPi-QEFJ4gbmfVOtrW2tZ-a1IQFg&hit%2Csum=WyI0dG5iaG0iLCI0dG5iaG4iLCI0dG5iaG8iXQ)
, the global leader in dental imaging technologies, is excited to announce its
participation in the International Dental Show (IDS)
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cuZW5nbGlzaC5pZHMtY29sb2duZS5kZS8&sig=SyXCldi4g9hVJbW4I8LxA-Jup4RSnyRiCGnQwjoOJ8lm4xlKWcayeWhZJaiO__aQydHDGMpNsXI6OD1-eOJNbA&hit%2Csum=WyI0dG5iaHAiLCI0dG5iaHEiLCI0dG5iaG8iXQ)
 2025 in Cologne, Germany.

Related Image
(https://cdn.nwe.io/files/x/9a/b8/4ac96776150e656c4d24cefd3213.png)

The company will showcase new technologies within the DEXIS digital ecosystem
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tdXM&sig=4yqQuhXOZxGUHGf-AFlynGat2s_cwMZxbRvLb4lNif8ZXeRx87bXacgzJrLPi-QEFJ4gbmfVOtrW2tZ-a1IQFg&hit%2Csum=WyI0dG5iaG0iLCI0dG5iaHIiLCI0dG5iaG8iXQ)
, an AI-powered platform that connects each step of the digital workflow, from
diagnosis to delivery. The ecosystem combines AI, 2D & 3D imaging,
intraoral scanning, diagnostics, and treatment planning to create one
integrated solution that streamlines processes and boosts productivity.

"We're excited to give IDS attendees the very first look at some of our new
technologies," says DEXIS President, Robert Befidi. "All of our innovations
are designed to improve patient interactions and make dental practices more
effective and efficient. We're eager to put our products into the hands of
dental professionals and demonstrate the capabilities of our new
technologies."

Among these innovations are some exciting updates to the DEXIS intraoral
scanning portfolio.
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tdXMvaW50cmFvcmFsLXNjYW5uaW5n&sig=MV03nDCori7qA0TXkn7QYC2C7rINN8IltI6tY6u-YPvmZyjo0OUok6AL4EuYf_Vawe0hoZsJqSIQ-ow9I_KYEg&hit%2Csum=WyI0dG5iaHMiLCI0dG5iaHQiLCI0dG5iaG8iXQ)
 Visitors will get an exclusive first look at the company's all-new intraoral
scanner under development, Imprevo. With a sleek new design, fully rebuilt
hardware, and AI-powered algorithm, Imprevo will become the new
high-performance flagship of the DEXIS IOS portfolio.

IS ScanFlow
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tdXMvZGV4aXMtaXMtc2NhbmZsb3c&sig=ClkMF9HLClrlMSuem8bYOEOBS-SlRbkdRUxKywqli4xxEyfs6hYkfAxc_MRY45JQXY06dl8l-zE1tj-wLEmuFA&hit%2Csum=WyI0dG5iaHUiLCI0dG5iaHYiLCI0dG5iaG8iXQ)
, the software that powers the DEXIS intraoral scanner line, will preview its
newest version, IS ScanFlow 2.0, featuring a new Smile Visualizer tool. The
tool will allow dental professionals to show patients a realistic preview of
their smile before and after treatments, helping them to visualize and better
understand treatment recommendations.

DEXIS will also unveil updates to the ORTHOPANTOMOGRAPH™ OP 3D™ EX
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cuZGV4aXMuY29tL2VuLXVzL29ydGhvcGFudG9tb2dyYXBoLW9wLTNkLWV4&sig=XoVRbSzDVrZ4b2ByeW12ib-q-BIx3fNJbZijRN-FZ62YY2UpCLIZT7f1TfSCWNo4EdXwiPe13M9IKBBJ13CZYg&hit%2Csum=WyI0dG5iaHciLCI0dG5iaHgiLCI0dG5iaG8iXQ)
, which will soon include cephalometric imaging capabilities. The new ceph
modality, which features the company's patented ORTHOceph™ Plus design, will
provide necessary protocols such as lateral and pediatric lateral projections,
posterior-anterior projections and carpus imaging* - all with fast scan times
and at a limited dose.

Additionally, the DEXIS 3D imaging portfolio will introduce an Automatic Dose
Control feature for the ORTHOPANTOMOGRAPH™ OP 3D™ LX.
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tdXMvb3AtM2QtbHg&sig=ORA1Isf7qhJYwcT7TTJhrrYFTi9_0Qdwo50eVk62mj1LMjHI8KN9O6h_RwkxSpAUNvNa69BBb9nV0WA3PtJa2A&hit%2Csum=WyI0dG5iaHkiLCI0dG5iaHoiLCI0dG5iaG8iXQ)
 The feature will measure patients' anatomy and automatically set exposure
levels for optimal image quality and dose. Early adopters have reported
positive feedback:

"The new Automatic Dose Control is one of the few things in life I don't have
to question," says Dr. Katya Archambault of San Diego Health Center. "It
offers both better and more consistent image quality. I could never argue with
the results."

Also being showcased are new features within DTX Studio™ Clinic
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tYXUvZHR4LXN0dWRpby1jbGluaWMtaW1hZ2luZy1zb2Z0d2FyZQ&sig=bFyCThWURxKXDI6Tp18dUIzR1GnebejvOBQKmzHLUTlJevmjHVJcxIC_9Tf_nHPx09OwcDO8-reKfG1qyF0Ybg&hit%2Csum=WyI0dG5iaTAiLCI0dG5iaTEiLCI0dG5iaG8iXQ)
, the core software of the DEXIS digital ecosystem. Known for its
comprehensive integration of all modalities of patient data, DTX Studio Clinic
streamlines diagnostics, patient education, treatment planning, and surgical
guide generation.

The software's new features include a suite of tools designed to streamline
the implant treatment planning process. Users can now plan an implant
treatment and generate an automated surgical template chairside in under 3
minutes. Additionally, the software introduces an Assisted Implant Planning
module that automates initial implant positioning, and a Face Scan tool that
integrates facial scans with 3D X-rays, further enhancing the planning
process.

Attendees will also get the chance to preview new innovations, set to be
released in future updates of DTX Studio Clinic. Among these innovations is a
new, AI-driven endodontic capability, that will provide 3D visualizations of
root canals, enhancing diagnostic accuracy and treatment efficiency.
Additionally, updates to the focus areas detection tool will be showcased,
enhancing the visualization of teeth in intraoral X-rays and detecting eight
additional dental findings.

DTX Studio Clinic will also introduce a new Cloud-based solution that will
allow clinicians to connect their practices and consolidate data in one place.
This feature is designed to enhance collaboration and streamline workflows,
ultimately improving practice efficiency and patient outcomes. These
advancements showcase the future of dental technology, making DTX Studio
Clinic an integral part of modern dentistry.

DEXIS invites all IDS attendees to visit Hall 11.2 K050 L069 to experience the
innovations that DEXIS has to offer. Their team of experts will be ready to
provide demonstrations and answer questions.

With more than 165,000 solutions in use around the world, DEXIS continues to
set the standard for quality and reliability in dental imaging. For more
information about DEXIS and its participation in IDS, please visit DEXIS @
IDS 2025.
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly90by5kZXhpcy5jb20vaWRzLWNvbG9nbmUtMjAyNQ&sig=R5E5DYZXyzpAJR6yt96PFrInvnZjVkjl7zDxseL91XixfOhe3cxUiw7xZ8C7cZdZq81saXNBllifJC8Rgeybzg&hit%2Csum=WyI0dG5iaTIiLCI0dG5iaTMiLCI0dG5iaG8iXQ)

About DEXIS

DEXIS is the global leader in dental imaging. We bring together the most
trusted brands in 2D and 3D imaging, intraoral scanning solutions, and
diagnostic software, in one connected and AI-powered ecosystem. Our innovative
and award-winning technologies use smart simplicity to increase productivity
and enhance diagnostic confidence. For more information, please
visit DEXIS.com.
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly9kZXhpcy5jb20vZW4tdXM&sig=4yqQuhXOZxGUHGf-AFlynGat2s_cwMZxbRvLb4lNif8ZXeRx87bXacgzJrLPi-QEFJ4gbmfVOtrW2tZ-a1IQFg&hit%2Csum=WyI0dG5iaG0iLCI0dHB4bnAiLCI0dG5iaG8iXQ)

About Envista

Envista Holdings Corporation is a global family of more than 30 trusted dental
brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared
purpose: to partner with professionals to improve lives. Envista helps its
customers deliver the best possible patient care through industry-leading
dental consumables, solutions, technology, and services. Its comprehensive
portfolio, including dental implants and treatment options, orthodontics, and
digital imaging technologies, covers a wide array of dentists' clinical needs
for diagnosing, treating, and preventing dental conditions as well as
improving the aesthetics of the human smile. With a foundation comprised of
the proven Envista Business System (EBS) methodology, an experienced
leadership team, and a strong culture grounded in continuous improvement,
commitment to innovation, and deep customer focus, Envista is well equipped to
meet the end-to-end needs of dental professionals worldwide. Envista is one of
the largest global dental products companies, with significant market
positions in some of the most attractive segments of the dental products
industry. For more information, please visit  www.envistaco.com
(https://stats.nwe.io/x/html?final=aHR0cHM6Ly93d3cuZW52aXN0YWNvLmNvbS8_X19oc3RjPTQxOTg1ODUwLjRjNTg3ODE2Nzg3MWQ5NjkxZWEzNzMzNjM0NTU1N2M5LjE3MTQ1MjQ0NDUyNjEuMTc0MDY3MzczNjk5MC4xNzQwNjgwMTEwNDEyLjIzMiZfX2hzc2M9NDE5ODU4NTAuMy4xNzQwNjgwMTEwNDEyJl9faHNmcD0yOTM1NzgzMTIy&sig=1LjpwvIKbRQztFGbyplpVBelm42aCUJE10KUCqRDILR31IpCv033plhYtLnW9VUNJIkqvZa3nWFHJGJLDQjMqw&hit%2Csum=WyI0dG5iaTUiLCI0dG5iaTYiLCI0dG5iaG8iXQ)
. 

DXIS01006/Rev00

*Carpus is an optional imaging program

Contact Information

Maria Penaloza

Media & Content Strategy Manager

mariap@accessnewswire.com

Michelle Cabral

Senior Marketing Director, DEXIS

michelle.cabral@envistaco.com

SOURCE: Envista

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEALDFALKSEFA